Pharmacoeconomic Evaluation in the Real World
- 1 January 1999
- journal article
- review article
- Published by Springer Science and Business Media LLC in PharmacoEconomics
- Vol. 15 (5), 423-434
- https://doi.org/10.2165/00019053-199915050-00001
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Long-term Outcomes of Initial Antidepressant Drug Choice in a "Real World" Randomized TrialArchives of Family Medicine, 1999
- When is a cost-effectiveness claim valid? How much should the FDA care?1997
- A Comparison of Clozapine and Haloperidol in Hospitalized Patients with Refractory SchizophreniaThe New England Journal of Medicine, 1997
- Telephone versus In-Person Clinical and Health Status Assessment Interviews in Patients with Bipolar DisorderHarvard Review of Psychiatry, 1997
- Confidence Intervals for Cost-Effectiveness Ratios: A Comparison of Four MethodsHealth Economics, 1997
- A randomized trial to assess effectiveness and cost in clinical practice: Rationale and design of the cholesterol reduction intervention study (CRIS)Controlled Clinical Trials, 1995
- Methods of pharmacoeconomic evaluation of new medical treatments in psychiatry.1995
- In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health CareMedical Care, 1994
- Statistical handling of drop‐outs in longitudinal clinical trialsStatistics in Medicine, 1992
- Clinical decision making: from theory to practice. What do we do about costs?JAMA, 1990